Sonorous Neurovascular Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort

Lake Forest, CA, USA – June 16th, 2025 – Sonorous Neurovascular, an innovative medical device company pioneering technological advancements for the treatment of symptomatic cerebrovascular venous diseases, announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. Sonorous Neurovascular is one of only 65 companies representing the top 4% of nearly 1,500 global applicants chosen for this year’s program.

MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.

“We are honored to join this year’s MedTech Innovator cohort,” said Dave Ferrera, CEO of Sonorous Neurovascular. “This opportunity gives us a powerful platform to validate our technology, build key partnerships, and accelerate our path to market.”

Sonorous Neurovascular was selected based on its innovative approach to treating patients suffering from debilitating pulsatile tinnitus due to cerebrovascular venous abnormalities, its potential to address an underserved patient population, and its alignment with MTI’s mission to improve patient care through transformative technology.

Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 5–8 in San Diego) and/or the MedTech Strategist Innovation Summit (November 19–21 in San Diego), where they will compete for a share of $800,000 in non-dilutive funding.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.